34034-9 |
Alveolar ridge trauma |
Find |
Gingiva |
Pt |
Ord |
|
|
ACTIVE |
Alveolar ridge trauma Gingiva |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DENTAL |
|
34034-9 |
|
|
|
|
|
|
|
|
0 |
Alv ridge trauma Gingiva |
|
|
|
N |
|
ALV; Alv ridge; Alv ridge trauma; Dental; Dentistry; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen |
2.27 |
2.09 |
|
|
|
|
|
|
|
|
|
|
|
0 |
34035-6 |
Alveolar ridge pathology |
Find |
Gingiva |
Pt |
Ord |
|
|
ACTIVE |
Alveolar ridge pathology Gingiva |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DENTAL |
|
34035-6 |
|
|
|
|
|
|
|
|
0 |
Alv ridge path Gingiva |
|
|
|
N |
|
ALV; Alv ridge; Alv ridge path; Dental; Dentistry; Finding; Findings; Ordinal; Path; Point in time; QL; Qual; Qualitative; Random; Screen |
2.27 |
2.09 |
|
|
|
|
|
|
|
|
|
|
|
0 |
34036-4 |
Keratinized gingiva |
Find |
Gingiva |
Pt |
Ord |
|
|
ACTIVE |
Keratinized gingiva |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DENTAL |
|
34036-4 |
|
|
|
|
|
|
|
|
0 |
Keratinized gingiva |
|
|
|
N |
|
Dental; Dentistry; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen |
2.56 |
2.09 |
|
|
|
|
|
|
|
|
|
|
Changed answer list from "Normative" to "Example" to fit the current LOINC model. |
0 |
34037-2 |
Size |
Arb |
Alveolar ridge |
Pt |
Ord |
Estimated |
|
ACTIVE |
Size Alveolar ridge Estimated |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DENTAL |
|
34037-2 |
|
Estimated |
|
|
|
|
|
|
0 |
Size Alv ridge Est |
|
|
|
N |
|
Alv ridge; Arbitrary; Dental; Dentistry; Est; estimation; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen |
2.27 |
2.09 |
|
|
|
|
|
|
|
|
|
|
|
0 |
34038-0 |
Problematic maxillary tuberosity |
Find |
Maxilla |
Pt |
Ord |
|
|
ACTIVE |
Problematic maxillary tuberosity |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DENTAL |
|
34038-0 |
|
|
|
|
|
|
|
|
0 |
Problem max tuberosity |
|
|
|
N |
|
Dental; Dentistry; Finding; Findings; Ordinal; Point in time; Problem max tuberosity; Ql; Qual; Qualitative; Random; Screen |
2.29 |
2.09 |
|
|
|
|
|
|
|
|
|
|
|
0 |
34039-8 |
Edentulous ridge relationship |
Find |
Maxilla.left+Mandible.left |
Pt |
Nom |
|
|
ACTIVE |
Edentulous ridge relationship Maxilla - left and Mandible - left |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DENTAL |
|
34039-8 |
|
|
|
|
|
|
|
|
0 |
Edent ridge rel Maxilla+Mandible-L |
|
|
|
N |
|
Dental; Dentistry; Edent ridge rel; Finding; Findings; Jaw; L; LT; Mand; Maxilla+Mandible-L; Nominal; Point in time; Random |
2.56 |
2.09 |
|
|
|
|
|
|
|
|
|
|
Changed answer list from "Normative" to "Example" to fit the current LOINC model. |
0 |
3404-1 |
Bolasterone |
MRat |
Urine |
24H |
Qn |
|
|
ACTIVE |
Bolasterone [Mass/time] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
ng/24 H |
|
|
|
|
|
|
DRUG/TOX |
|
3404-1 |
|
|
|
|
Both |
|
|
|
0 |
Bolasterone 24h Ur-mRate |
|
|
|
Y |
|
1 day; 24 hours; 24HR; DRUG/TOXICOLOGY; Drugs; Mass rate; mRate; QNT; Quan; Quant; Quantitative; UA; UR; Urn |
2.42 |
1 |
|
|
|
|
|
|
|
ng/(24.h) |
|
|
|
0 |
34040-6 |
Edentulous ridge relationship |
Find |
Maxilla.right+Mandible.right |
Pt |
Nom |
|
|
ACTIVE |
Edentulous ridge relationship Maxilla - right and Mandible - right |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DENTAL |
|
34040-6 |
|
|
|
|
|
|
|
|
0 |
Edent ridge rel Maxilla+Mandible-R |
|
|
|
N |
|
Dental; Dentistry; Edent ridge rel; Finding; Findings; Jaw; Mand; Maxilla+Mandible-R; Nominal; Point in time; R; Random; RT |
2.56 |
2.09 |
|
|
|
|
|
|
|
|
|
|
Changed answer list from "Normative" to "Example" to fit the current LOINC model. |
0 |
34041-4 |
Partial edentulism classification |
Class |
{Dental arch} |
Pt |
Nom |
Kennedy classification |
|
ACTIVE |
Partial edentulism {Dental arch} Kennedy classification |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DENTAL |
|
34041-4 |
|
Kennedy classification |
|
|
|
|
|
|
0 |
Partial edent {Dent arch} Kennedy |
|
|
|
N |
|
{Dent arch}; Dental; Dentistry; Nominal; Point in time; Random |
2.29 |
2.09 |
|
|
|
|
|
|
|
|
|
|
|
0 |
34042-2 |
Partially endentulous maxillectomy classification |
Class |
Maxilla |
Pt |
Nom |
Aramany classification |
|
ACTIVE |
Partially endentulous maxillectomy Aramany classification |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DENTAL |
|
34042-2 |
|
Aramany classification |
|
|
|
|
|
|
0 |
Partial endent max Aramany |
|
|
|
N |
|
Dental; Dentistry; Nominal; Partial endent max; Point in time; Random |
2.34 |
2.09 |
|
|
|
|
|
|
|
|
|
|
|
0 |
34043-0 |
Dental examination method |
Type |
Dentition |
Pt |
Nom |
* |
|
ACTIVE |
Dental examination method Dentition |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DENTAL |
|
34043-0 |
|
* |
|
|
|
|
|
|
0 |
Dent exam method Dentition |
|
|
|
N |
|
Dent exam method; Dental; Dentistry; Meth; Method of; Nominal; Point in time; Random; Typ |
2.27 |
2.09 |
|
|
|
|
|
|
|
|
|
|
|
0 |
34044-8 |
Magnification instrument |
Type |
^Patient |
Pt |
Nom |
|
|
ACTIVE |
Magnification instrument |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DENTAL |
|
34044-8 |
|
|
|
|
|
|
|
|
0 |
Magnification instrument |
|
|
|
N |
|
Nominal; Point in time; Random; Typ |
2.56 |
2.09 |
|
|
|
|
|
|
|
|
|
|
Changed answer list from "Normative" to"Example" to fit the current LOINC model. |
0 |
34045-5 |
Oral evaluation exam |
Type |
^Patient |
Pt |
Nom |
|
|
ACTIVE |
Oral evaluation exam |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DENTAL |
|
34045-5 |
|
|
|
|
|
|
|
|
0 |
Oral eval exam |
|
|
|
N |
|
Assessment; Dental; Dentistry; Eval; H&P; History and physical; Nominal; Oral eval exam; Point in time; Random; Typ |
2.73 |
2.09 |
|
|
|
|
|
|
|
|
|
|
|
0 |
34046-3 |
Medical history contribution |
Find |
{Chief complaint} |
Pt |
Ord |
|
|
ACTIVE |
Medical history contribution {Chief complaint} |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DENTAL |
|
34046-3 |
|
|
|
|
|
|
|
|
0 |
Medical Hx contrib {Chief complaint} |
|
|
|
N |
|
Finding; Findings; Hx; Medical Hx contrib; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen |
2.27 |
2.09 |
|
|
|
|
|
|
|
|
|
|
|
0 |
34047-1 |
Dental history contribution |
Find |
{Chief complaint} |
Pt |
Ord |
|
|
ACTIVE |
Dental history contribution {Chief complaint} |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DENTAL |
|
34047-1 |
|
|
|
|
|
|
|
|
0 |
Dent Hx contribution {Chief complaint} |
|
|
|
N |
|
Dent Hx contribution; Dental; Dentistry; Finding; Findings; Hx; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen |
2.27 |
2.09 |
|
|
|
|
|
|
|
|
|
|
|
0 |
34048-9 |
Dental material used &or Proposed |
Type |
^Patient |
Pt |
Nom |
|
|
ACTIVE |
Dental material used/Proposed |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DENTAL |
|
34048-9 |
|
|
|
|
|
|
|
|
0 |
Dent material used/Proposed |
|
|
|
N |
|
Dent material used/Proposed; Dental; Dentistry; Nominal; Point in time; Random; Typ |
2.56 |
2.09 |
|
|
|
|
|
|
|
|
|
|
Changed answer list from "Normative" to "Example" to fit the current LOINC model. |
0 |
34049-7 |
Number of impressions |
Num |
Dentition |
Pt |
Qn |
|
|
ACTIVE |
Number of impressions Dentition |
|
MIN |
DefinitionDescription |
|
|
# |
|
|
|
|
|
|
DENTAL |
|
34049-7 |
|
|
|
|
|
|
|
|
0 |
# impressions Dentition |
|
|
|
N |
|
# impressions; Cnt; Count; Dental; Dentistry; No; Num; Number; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.48 |
2.09 |
|
|
|
|
|
|
|
{#} |
|
|
|
0 |
3405-8 |
Bromazepam |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Bromazepam [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
3405-8 |
|
|
|
|
Both |
|
|
|
0 |
Bromazepam SerPl-mCnc |
|
|
|
Y |
|
Bromazanil; Brozam; Calmepam; Compendium; Creosedin; DRUG/TOXICOLOGY; Drugs; Durazanil; Gityl; Lectopam; Level; Lexatin; Lexaurin; Lexonil; Lexotan; Lexotanil; Mass concentration; Neo-opt; Normoc; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somalium; SR |
2.42 |
1 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
34050-5 |
Bone height |
Len |
{First bone reference}+{Second bone reference} |
Pt |
Qn |
Measured |
|
ACTIVE |
Bone height {First bone reference}+{Second bone reference} Measured |
|
MIN |
DefinitionDescription |
|
|
cm |
|
|
|
|
|
|
DENTAL |
|
34050-5 |
|
Measured |
|
|
|
|
|
|
0 |
Bne height 1st+2nd {bne ref} Measured |
|
|
|
N |
|
1st+2nd {bne ref}; 2nd; Bne height; BON; Length; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.48 |
2.09 |
|
|
|
|
|
|
|
cm |
|
|
|
0 |
34051-3 |
Bone width |
Len |
{First bone reference}+{Second bone reference} |
Pt |
Qn |
Measured |
|
ACTIVE |
Bone width {First bone reference}+{Second bone reference} Measured |
|
MIN |
DefinitionDescription |
|
|
cm |
|
|
|
|
|
|
DENTAL |
|
34051-3 |
|
Measured |
|
|
|
|
|
|
0 |
Bne width 1st+2nd {bne ref} Measured |
|
|
|
N |
|
1st+2nd {bne ref}; 2nd; Bne width; BON; Length; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.48 |
2.09 |
|
|
|
|
|
|
|
cm |
|
|
|
0 |
34052-1 |
Bone length |
Len |
{First bone reference}+{Second bone reference} |
Pt |
Qn |
Measured |
|
ACTIVE |
Bone length {First bone reference}+{Second bone reference} Measured |
|
MIN |
DefinitionDescription |
|
|
cm |
|
|
|
|
|
|
DENTAL |
|
34052-1 |
|
Measured |
|
|
|
|
|
|
0 |
Bne length 1st+2nd {bne ref} Measured |
|
|
|
N |
|
1st+2nd {bne ref}; 2nd; Bne length; BON; Len; Length; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.48 |
2.09 |
|
|
|
|
|
|
|
cm |
|
|
|
0 |
34053-9 |
Xylose^2H post 5 g xylose PO |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Xylose [Moles/volume] in Serum or Plasma --2 hours post 5 g xylose PO |
|
MIN |
DefinitionDescription |
|
|
mmol/L;nmol/L |
|
|
|
|
|
|
CHAL |
|
34053-9 |
|
|
|
|
Observation |
|
|
|
0 |
Xylose 2h p 5 g Xyl PO SerPl-sCnc |
|
|
|
N |
|
120 min; 120 minutes; 120min; 2 hours; 2h p 5 g Xyl PO; After; CHEMISTRY.CHALLENGE TESTING; D-xylose; Level; p 5 g Xyl PO; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Xylose absorption test |
2.7 |
2.09 |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
34054-7 |
Thyrotropin^pre or post dose TRH |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Thyrotropin [Units/volume] in Serum or Plasma --pre or post dose TRH |
|
MIN |
DefinitionDescription |
|
|
mIU/L;mcU/mL |
|
|
|
|
|
|
CHAL |
|
34054-7 |
|
|
|
|
Observation |
|
|
|
0 |
TSH pre/p TRH SerPl-aCnc |
|
|
|
N |
|
After; Arbitrary concentration; Before; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; p dose; p TRH; Pl; Plasma; Plsm; Point in time; pre/p TRH; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thyroid stimulating hormone; Thyrotropic hormone; TSH |
2.7 |
2.09 |
|
|
|
|
|
|
|
m[IU]/L |
|
|
|
0 |
34055-4 |
Lutropin^pre or post XXX challenge |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Lutropin [Units/volume] in Serum or Plasma --pre or post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
mIU/mL;IU/L |
|
|
|
|
|
|
CHAL |
|
34055-4 |
|
|
|
|
Observation |
|
|
|
0 |
LH pre/p chal SerPl-aCnc |
|
|
|
N |
|
After; Arbitrary concentration; Before; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; ICSH; Interstitial cell-stimulating hormone; Interstitual cell stimulating hormone; Leutinizing hormone; LH; Luteinizing hormone; Lutenin; Lutenizing hormone; Ovulation test; p chal; Pl; Plasma; Plsm; Point in time; pre/p chal; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.68 |
2.09 |
|
|
|
|
|
|
|
m[IU]/mL |
|
|
|
0 |
34056-2 |
Glucose^pre or post dose arginine |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Glucose [Moles/volume] in Serum or Plasma --pre or post dose arginine |
|
MIN |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
CHAL |
|
34056-2 |
|
|
|
|
Observation |
|
|
|
0 |
Glucose pre/p Arg SerPl-sCnc |
|
|
|
N |
|
After; Arg; Before; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; p dose; Pl; Plasma; Plsm; Point in time; pre/p Arg; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.7 |
2.09 |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |